Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Armand

Showing results (121-130 of 240) with videos related to

Pageof 24
Sort By:
Investigational New Drugs|December 1, 1988
Phase II study of mitozolomide (M & B 39,565) in colorectal and breast cancerP Herait, P Rougier, J Oliveira, et al.
Seminars in Oncology|April 4, 2001
Docetaxel (Taxotere) shows survival and quality-of-life benefits in the second-line treatment of non-small cell lung cancer: a review of two phase III trialsF A Shepherd, F V Fossella, T Lynch, et al.
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|December 16, 1982
[Chemotherapy in advanced malignant melanoma. Results of a controlled trial comparing a combination of dacarbazine (DTIC) and detorubicin with dacarbazine alone]J Chauvergne, N B Bui, P Cappelaere, et al.
American Journal of Clinical Oncology|October 1, 1990
Phase II study of cisplatin and continuous-infusion 5-fluorouracil and bleomycin for recurrent and metastatic head and neck squamous-cell carcinomaE Tellez-Bernal, M Belehradek, G Recondo, et al.
Journal of Chromatography|March 27, 1992
Simultaneous determination of the camptothecin analogue CPT-11 and its active metabolite SN-38 by high-performance liquid chromatography: application to plasma pharmacokinetic studies in cancer patientsI Barilero, D Gandia, J P Armand, et al.
European Journal of Cancer (Oxford, England : 1990)|October 3, 2003
Nasopharyngeal carcinomas: an updateJ-P Spano, P Busson, D Atlan, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
European School of Oncology Advisory Report to the Commission of the European Communities for the "Europe Against Cancer Programme." Continuing Medical Education in Oncology within the European UnionJ P Armand, P Alberto, A Costa, et al.
International Journal of Cancer|May 4, 1995
Mutations clustered in exon 5 of the p53 gene in primary nasopharyngeal carcinomas from southeastern AsiaF Chakrani, J P Armand, G Lenoir, et al.
Folding & Design|January 1, 1997
Chiral N-substituted glycines can form stable helical conformationsP Armand, K Kirshenbaum, A Falicov, et al.
Journal of Neuro-Oncology|January 1, 1993
Pilot study of 6 weeks of chemoradiotherapy with 5 FU and hydroxyurea in malignant gliomasF B Cvitkovic, C Haie-Meder, V Papadimitrakopoulou, et al.
Pageof 24

Showing results (121-130 of 240) with videos related to

Sort By:
Pageof 24
Investigational New Drugs|December 1, 1988
Phase II study of mitozolomide (M & B 39,565) in colorectal and breast cancerP Herait, P Rougier, J Oliveira, et al.
Seminars in Oncology|April 4, 2001
Docetaxel (Taxotere) shows survival and quality-of-life benefits in the second-line treatment of non-small cell lung cancer: a review of two phase III trialsF A Shepherd, F V Fossella, T Lynch, et al.
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|December 16, 1982
[Chemotherapy in advanced malignant melanoma. Results of a controlled trial comparing a combination of dacarbazine (DTIC) and detorubicin with dacarbazine alone]J Chauvergne, N B Bui, P Cappelaere, et al.
American Journal of Clinical Oncology|October 1, 1990
Phase II study of cisplatin and continuous-infusion 5-fluorouracil and bleomycin for recurrent and metastatic head and neck squamous-cell carcinomaE Tellez-Bernal, M Belehradek, G Recondo, et al.
Journal of Chromatography|March 27, 1992
Simultaneous determination of the camptothecin analogue CPT-11 and its active metabolite SN-38 by high-performance liquid chromatography: application to plasma pharmacokinetic studies in cancer patientsI Barilero, D Gandia, J P Armand, et al.
European Journal of Cancer (Oxford, England : 1990)|October 3, 2003
Nasopharyngeal carcinomas: an updateJ-P Spano, P Busson, D Atlan, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
European School of Oncology Advisory Report to the Commission of the European Communities for the "Europe Against Cancer Programme." Continuing Medical Education in Oncology within the European UnionJ P Armand, P Alberto, A Costa, et al.
International Journal of Cancer|May 4, 1995
Mutations clustered in exon 5 of the p53 gene in primary nasopharyngeal carcinomas from southeastern AsiaF Chakrani, J P Armand, G Lenoir, et al.
Folding & Design|January 1, 1997
Chiral N-substituted glycines can form stable helical conformationsP Armand, K Kirshenbaum, A Falicov, et al.
Journal of Neuro-Oncology|January 1, 1993
Pilot study of 6 weeks of chemoradiotherapy with 5 FU and hydroxyurea in malignant gliomasF B Cvitkovic, C Haie-Meder, V Papadimitrakopoulou, et al.
Pageof 24